Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Baylor College of Medicine |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00767845 |
RATIONALE: Gathering information about symptom management from patients with localized prostate cancer may help doctors improve patients' quality of life.
PURPOSE: This clinical trial is studying symptom management in African-American men with localized prostate cancer.
Condition | Intervention |
---|---|
Cancer-Related Problem/Condition Prostate Cancer |
Procedure: psychosocial assessment and care Procedure: questionnaire administration Procedure: survey administration |
Study Type: | Interventional |
Study Design: | Health Services Research |
Official Title: | PROSTATE CANCER SYMPTOM MANAGEMENT FOR LOW LITERACY MEN |
Estimated Enrollment: | 30 |
Study Start Date: | May 2008 |
Estimated Primary Completion Date: | May 2009 (Final data collection date for primary outcome measure) |
OBJECTIVES:
OUTLINE: Participants are interviewed by the principal investigator over the phone or meet the principal investigator at the Veterans Administration prostate cancer clinic. If the interview is conducted in the clinic, it is held in a private room in the clinic.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Biopsy-proven localized prostate cancer
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
United States, Texas | |
Dan L. Duncan Cancer Center at Baylor College of Medicine | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: David Latini, PhD 877-794-7852 canceroutcomes@bcm.edu |
Principal Investigator: | David Latini, PhD | Baylor College of Medicine |
Study ID Numbers: | CDR0000600455, BCM-H-19323 |
Study First Received: | October 4, 2008 |
Last Updated: | November 18, 2008 |
ClinicalTrials.gov Identifier: | NCT00767845 |
Health Authority: | Unspecified |
psychosocial effects/treatment stage I prostate cancer stage II prostate cancer stage III prostate cancer |
Prostatic Diseases Genital Neoplasms, Male Urogenital Neoplasms Genital Diseases, Male Prostatic Neoplasms |
Neoplasms Neoplasms by Site |